胆囊癌电化学microRNA生物传感器:临床化学与即时诊断的转化前景
本综述评估用于检测胆囊癌的miRNA电化学生物传感器,涵盖分析性能、灵敏度、特异性、检测限、分析前变量及临床验证。文章概述胆囊癌相关miRNA特征及其特异性,讨论信号转导与纳米材料界面策略,并将传感器性能与RT-qPCR和微滴数字PCR进行比较。综述提供转化概念框架,桥接miRNA病理生物学、检测工程与实验室医学,以指导临床诊断工具的设计与实施。
要点
- 血清、血浆和胆汁中的循环miRNA是稳定、微创的胆囊癌液体活检标志物。
- 电化学miRNA生物传感器需在临床相关基质中验证特异性、检测限和稳健性。
- 胆汁复杂成分(胆盐、蛋白质、pH变化)可导致电极污染等分析挑战。
核心结论
- 电化学miRNA生物传感器有望作为胆囊癌临床诊断工具,但需解决特异性、临床基质中检测限、稳健性及分析变异来源等问题。
研究设计与样本
- 综述类文章,评估已开发的用于检测胆囊癌的miRNA电化学生物传感器,涵盖分析性能、临床基质验证及与常规分子方法比较。
主要发现
- 循环miRNA在血清、血浆和胆汁中稳定且微创,可指示胆囊癌生物学特征并用于液体活检诊断。
- 胆汁中胆盐、蛋白质和pH变化可导致电极污染等分析挑战。
- 生物传感器性能需与RT-qPCR和微滴数字PCR等常规分子方法进行比较评估。
关键数值与推荐
- 评估生物传感器在临床相关基质中的灵敏度、特异性、检测限、稳健性及分析和生物学变异来源。
- 关注miRNA对胆囊癌相对于其他恶性肿瘤和炎症反应的特异性。
临床怎么用
- 电化学生物传感器可整合至中心实验室和即时诊断流程,用于诊断、鉴别恶性和炎症性胆道病变、风险评估及治疗胆囊癌。
- 转化框架可指导miRNA电化学传感器作为临床诊断工具的设计与实施。
局限性
- 胆汁复杂成分(胆盐、蛋白质、pH变化)可导致电极污染等分析挑战。
- 需在临床相关基质中验证特异性、检测限和稳健性,并评估分析与生物学变异来源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Gallbladder cancer is a biliary malignancy characterized by a high mortality rate, primarily due to the limitations of current serum biomarkers and imaging techniques in detecting the disease at an early stage. Circulating microRNAs (miRNAs) in serum, plasma, and bile are stable, less invasive biomarkers that are indicative of the biology of gallbladder cancer and have the potential for diagnostics through liquid biopsy. This review critically evaluates miRNA-based electrochemical biosensors that have been developed to detect gallbladder cancer, including their analytical performance, sensitivity, specificity, and detection limits in clinically relevant matrices, preanalytical variables, and analytical and clinical validation in clinical laboratories. We provide a brief overview of the relevant miRNA signatures in disease, their specificity to gallbladder cancer over other malignancies and inflammatory responses, comment on the approaches to transduction and nanomaterial-engineered interfaces in the detection of sensitive miRNAs in human biofluids, and critique the performance of biosensors in relation to the conventional molecular procedures, such as RT-qPCR and droplet digital PCR (ddPCR). In routine applications, particular emphasis is placed on specificity, detection limits in clinically relevant matrices, robustness, and sources of both analytical and biological variability. This encompasses the complex composition of bile, which includes bile salts, proteins, and pH changes that can pose challenges such as electrode fouling. We also describe how these biosensors are integrated into central laboratories and point-of-care procedures to diagnose, differentiate between malignant and inflammatory biliary lesions, assess risks, and treat gallbladder cancer. The review provides a conceptual framework of translation that reinforces the purpose and reasoning behind the implementation of electrochemical biosensors in clinical oncology by bridging miRNA pathobiology with miRNA electrochemical biosensors assay engineering and laboratory medicine issues to guide the design and implementation of miRNA electrochemical biosensors as a clinical diagnostic tool.
引用
- Goyal A, Hajarnavis AM, Jakhmola V, et al. Electrochemical microRNA biosensors for gallbladder cancer: Translational perspectives for clinical chemistry and point-of-care diagnostics. Clin Chim Acta. 2026. PMID: 42019746. doi:10.1016/j.cca.2026.121016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。